Newsletter

Fibrodysplasia Ossificans Progressiva
With no cure at hand Pharma companies gear up to offer relief to patients suffering from a sporadic connective tissue disease.
Fibrodysplasia Ossificans Progressiva

More Whitepapers / Newsletters

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required..

Raynauds phenomenon Newsletter
Raynaud's phenomenon

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused by episodic vasospasm...

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide.

Complex Regional Pain Syndrome Newsletter
Complex Regional Pain Syndrome

A chronic pain condition, Complex Regional Pain Syndrome (CRPS) often affects one limb and is believed to be caused by injury, or malfunction of..

Evolution of Precision Medicine in Oncology Whitepaper
Evolution of Precision Medicine in Oncology

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and..